Corporate Profile

At SOPHiA GENETICS, we are bringing the power of data and artificial intelligence to healthcare. Our AI platform analyzes multimodal data - including genomics, radiomics, clinical, biological, and digital pathology data - to generate actionable insights for patients with cancer or rare diseases.

Today, over 780 healthcare institutions use our cloud-native, consumption-based SaaS platform to bring the power of data-driven medicine to millions of patients across the globe. Beyond the clinical market, our platform is used by BioPharma partners for AI-powered drug discovery, development, and deployment.

Investor Events
Tuesday, November 5, 2024
8:00am - 9:00am EST
Tuesday, September 10, 2024
3:15pm - 4:00pm EDT

View all events

Press Releases
Nov 5, 2024

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today announced that Ross Muken, previously Chief Financial Officer ("CFO") and Chief Operating...

Nov 5, 2024

Clinical growth reaccelerates with record analysis volume; Cash burn improves 39% BOSTON and ROLLE, Switzerland, Nov. 5, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native...

Oct 22, 2024

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the third quarter of fiscal year...

View all releases

Stock Information

View current and historic stock prices, analyst information, and more

Financial Information

Download quarterly earnings reports, supplementary data, SEC filings, and more

Corporate Governance

Learn about our governance guidelines, code of ethics, Board of Directors, and more

Email Alerts
To opt-in for investor email alerts, please enter your email address. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
* Required Fields
Contact Us

General Inquiries

SOPHiA GENETICS
La Pièce 12, CH-1180
Rolle, Switzerland
+41 21 694 10 60

ir@sophiagenetics.com

Transfer Agent

Computershare Trust Company, N.A.
Courier Delivery:
P.O. Box 43006
Providence RI 02940-3006
Overnight Delivery:
150 Royall St. STE 101
Canton, MA 02021

877.373.6374
www.computershare.com